Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study.

The current work provides evidence to support the causality of the six circulating metabolites on CRC and a new perspective on the exploration of the biological mechanisms of CRC by combining genomics and metabolomics. These findings contribute to the screening, prevention and treatment of CRC.